424 related articles for article (PubMed ID: 8368636)
21. An arthroconidial-spherule antigen of Coccidioides immitis: differential expression during in vitro fungal development and evidence for humoral response in humans after infection or vaccination.
Galgiani JN; Sun SH; Dugger KO; Ampel NM; Grace GG; Harrison J; Wieden MA
Infect Immun; 1992 Jul; 60(7):2627-35. PubMed ID: 1612732
[TBL] [Abstract][Full Text] [Related]
22. Coccidioidomycosis in the U.S. Military: a review.
Crum-Cianflone NF
Ann N Y Acad Sci; 2007 Sep; 1111():112-21. PubMed ID: 17435116
[TBL] [Abstract][Full Text] [Related]
23. Both CD4+ and CD8+ T cells can mediate vaccine-induced protection against Coccidioides immitis infection in mice.
Fierer J; Waters C; Walls L
J Infect Dis; 2006 May; 193(9):1323-31. PubMed ID: 16586371
[TBL] [Abstract][Full Text] [Related]
24. Role of signal sequence in vaccine-induced protection against experimental coccidioidomycosis.
Jiang C; Magee DM; Ivey FD; Cox RA
Infect Immun; 2002 Jul; 70(7):3539-45. PubMed ID: 12065493
[TBL] [Abstract][Full Text] [Related]
25. An agonist of human complement fragment C5a enhances vaccine immunity against Coccidioides infection.
Hung CY; Hurtgen BJ; Bellecourt M; Sanderson SD; Morgan EL; Cole GT
Vaccine; 2012 Jun; 30(31):4681-90. PubMed ID: 22575167
[TBL] [Abstract][Full Text] [Related]
26. A recombinant aspartyl protease of Coccidioides posadasii induces protection against pulmonary coccidioidomycosis in mice.
Tarcha EJ; Basrur V; Hung CY; Gardner MJ; Cole GT
Infect Immun; 2006 Jan; 74(1):516-27. PubMed ID: 16369008
[TBL] [Abstract][Full Text] [Related]
27. Whole glucan particles as a vaccine against systemic coccidioidomycosis.
Clemons KV; Antonysamy MA; Danielson ME; Michel KS; Martinez M; Chen V; Stevens DA
J Med Microbiol; 2015 Oct; 64(10):1237-1243. PubMed ID: 26297127
[TBL] [Abstract][Full Text] [Related]
28. Some evidence for the development of a phagocytic response by polymorphonuclear leukocytes recovered from the venous blood of dogs inoculated with Coccidioides immitis or vaccinated with an irradiated spherule vaccine.
Wegner TN; Reed RE; Trautman RJ; Beavers CD
Am Rev Respir Dis; 1972 May; 105(5):845-9. PubMed ID: 5020634
[No Abstract] [Full Text] [Related]
29. Evaluation of two homologous proline-rich proteins of Coccidioides posadasii as candidate vaccines against coccidioidomycosis.
Herr RA; Hung CY; Cole GT
Infect Immun; 2007 Dec; 75(12):5777-87. PubMed ID: 17875631
[TBL] [Abstract][Full Text] [Related]
30. Coccidioidomycosis outbreak among United States Navy SEALs training in a Coccidioides immitis-endemic area--Coalinga, California.
Crum N; Lamb C; Utz G; Amundson D; Wallace M
J Infect Dis; 2002 Sep; 186(6):865-8. PubMed ID: 12198626
[TBL] [Abstract][Full Text] [Related]
31. Resistance to Coccidioides immitis in mice after immunization with recombinant protein or a DNA vaccine of a proline-rich antigen.
Abuodeh RO; Shubitz LF; Siegel E; Snyder S; Peng T; Orsborn KI; Brummer E; Stevens DA; Galgiani JN
Infect Immun; 1999 Jun; 67(6):2935-40. PubMed ID: 10338502
[TBL] [Abstract][Full Text] [Related]
32. Seroprevalence of antibodies against Coccidioides immitis in healthy horses.
Higgins JC; Leith GS; Voss ED; Pappagianis D
J Am Vet Med Assoc; 2005 Jun; 226(11):1888-92. PubMed ID: 15934257
[TBL] [Abstract][Full Text] [Related]
33. Coccidioides immitis and posadasii; A review of their biology, genomics, pathogenesis, and host immunity.
Kirkland TN; Fierer J
Virulence; 2018; 9(1):1426-1435. PubMed ID: 30179067
[TBL] [Abstract][Full Text] [Related]
34. Protective immunity in coccidioidomycosis.
Cox RA; Magee DM
Res Immunol; 1998; 149(4-5):417-28; discussion 506-7. PubMed ID: 9720959
[No Abstract] [Full Text] [Related]
35. Viable spores of Coccidioides posadasii Δcps1 are required for vaccination and provide long lasting immunity.
Shubitz LF; Powell DA; Trinh HT; Lewis ML; Orbach MJ; Frelinger JA; Galgiani JN
Vaccine; 2018 May; 36(23):3375-3380. PubMed ID: 29724507
[TBL] [Abstract][Full Text] [Related]
36. CARD9-Associated Dectin-1 and Dectin-2 Are Required for Protective Immunity of a Multivalent Vaccine against
Campuzano A; Zhang H; Ostroff GR; Dos Santos Dias L; Wüthrich M; Klein BS; Yu JJ; Lara HH; Lopez-Ribot JL; Hung CY
J Immunol; 2020 Jun; 204(12):3296-3306. PubMed ID: 32358020
[No Abstract] [Full Text] [Related]
37. Characteristics of the protective subcellular coccidioidal T27K vaccine.
Johnson SM; Kerekes KM; Lunetta JM; Pappagianis D
Ann N Y Acad Sci; 2007 Sep; 1111():275-89. PubMed ID: 17363436
[TBL] [Abstract][Full Text] [Related]
38. Immunization of mice with induced mutants of Coccidioides immitis. I. Characterization of mutants and preliminary studies of their use as viable vaccines.
Walch HA; Kalvoda A
Sabouraudia; 1971 Nov; 9(3):173-84. PubMed ID: 5135085
[No Abstract] [Full Text] [Related]
39. The public health impact of coccidioidomycosis in Arizona and California.
Hector RF; Rutherford GW; Tsang CA; Erhart LM; McCotter O; Anderson SM; Komatsu K; Tabnak F; Vugia DJ; Yang Y; Galgiani JN
Int J Environ Res Public Health; 2011 Apr; 8(4):1150-73. PubMed ID: 21695034
[TBL] [Abstract][Full Text] [Related]
40. Novel strategies to enhance vaccine immunity against coccidioidomycosis.
Cole GT; Hung CY; Sanderson SD; Hurtgen BJ; Wüthrich M; Klein BS; Deepe GS; Ostroff GR; Levitz SM
PLoS Pathog; 2013; 9(12):e1003768. PubMed ID: 24367252
[No Abstract] [Full Text] [Related]
[Previous] [Next] [New Search]
